Related Experiment Video
Updated: Mar 19, 2026

Microscopic Electric Rotary Grinding of Plaques Combined with Graft Repair in the Management of Peyronie's Disease
Published on: March 15, 2024
Multidisciplinary Care of Patients With Penile Cancer
Luis G Medina1,2, Firas Hatoum3, Nahuel Paesano2,4
1Department of Urology, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC.
Abstract:
Penile squamous cell carcinoma (PSCC) is a rare malignancy that displays profound disparities in incidence, access to care, and clinical outcomes rooted in economic, social differences, and cultural practices. PSCC has been linked to high treatment-related morbidity, social stigma, and psychological distress. This chapter provides an overview of this disease, integrating epidemiology, pathology, imaging, and multimodal management strategies. The principles of penile cancer staging, histopathologic features, and the role of imaging in local staging of the primary tumor and nodal disease are also covered. As multimodal mkanagement has become increasingly central in penile, the role of inguinal lymph node dissection, sentinel lymph node biopsy, radiotherapy, and the current state of systemic therapies are also discussed. In addition, we discuss the growing roles of patient advocacy and psychosocial support, which are often overlooked, and highlights disparities in care and quality of life, as well as the importance of centralized cancer care. Advancing care in PSCC will require a concerted multidisciplinary effort and a pledge to patient-centered advocacy as well as global initiatives.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Treatment Resistant Cancers
Treatment Resistent Cancers
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
Peripheral Artery Disease V: Postoperative Nursing Management
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

